These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8923458

  • 1. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.
    Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine ID, Vigneri R.
    Mol Endocrinol; 1996 Nov; 10(11):1318-26. PubMed ID: 8923458
    [Abstract] [Full Text] [Related]

  • 2. Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity.
    Costantino A, Milazzo G, Giorgino F, Russo P, Goldfine ID, Vigneri R, Belfiore A.
    Mol Endocrinol; 1993 Dec; 7(12):1667-76. PubMed ID: 8145772
    [Abstract] [Full Text] [Related]

  • 3. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.
    Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA.
    Nature; 1995 Feb 02; 373(6513):448-51. PubMed ID: 7830796
    [Abstract] [Full Text] [Related]

  • 4. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit.
    Maddux BA, Goldfine ID.
    Diabetes; 2000 Jan 02; 49(1):13-9. PubMed ID: 10615944
    [Abstract] [Full Text] [Related]

  • 5. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM.
    Shao J, Catalano PM, Yamashita H, Ruyter I, Smith S, Youngren J, Friedman JE.
    Diabetes; 2000 Apr 02; 49(4):603-10. PubMed ID: 10871198
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated plasma cell membrane glycoprotein levels and diminished insulin receptor autophosphorylation in obese, insulin-resistant rhesus monkeys.
    Pender C, Ortmeyer HK, Hansen BC, Goldfine ID, Youngren JF.
    Metabolism; 2002 Apr 02; 51(4):465-70. PubMed ID: 11912555
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity.
    Costantino A, Vinci C, Mineo R, Frasca F, Pandini G, Milazzo G, Vigneri R, Belfiore A.
    Endocrinology; 1996 Oct 02; 137(10):4100-7. PubMed ID: 8828463
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site.
    Kumakura S, Maddux BA, Sung CK.
    J Cell Biochem; 1998 Mar 01; 68(3):366-77. PubMed ID: 9518262
    [Abstract] [Full Text] [Related]

  • 10. Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance.
    Whitehead JP, Humphreys PJ, Dib K, Goding JW, O'Rahilly S.
    Clin Endocrinol (Oxf); 1997 Jul 01; 47(1):65-70. PubMed ID: 9302374
    [Abstract] [Full Text] [Related]

  • 11. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity.
    Frittitta L, Youngren J, Vigneri R, Maddux BA, Trischitta V, Goldfine ID.
    Diabetologia; 1996 Oct 01; 39(10):1190-5. PubMed ID: 8897006
    [Abstract] [Full Text] [Related]

  • 12. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling.
    Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R, Trischitta V.
    Diabetes; 1998 Jul 01; 47(7):1095-100. PubMed ID: 9648833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine.
    Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart TA.
    J Biol Chem; 1995 Sep 22; 270(38):22085-8. PubMed ID: 7673181
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK.
    Cancer Res; 1992 Jul 01; 52(13):3636-41. PubMed ID: 1617636
    [Abstract] [Full Text] [Related]

  • 17. Insulin modulates PC-1 processing and recruitment in cultured human cells.
    Menzaghi C, Di Paola R, Baj G, Funaro A, Arnulfo A, Ercolino T, Surico N, Malavasi F, Trischitta V.
    Am J Physiol Endocrinol Metab; 2003 Mar 01; 284(3):E514-20. PubMed ID: 12441313
    [Abstract] [Full Text] [Related]

  • 18. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
    Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L.
    Endocr Rev; 2008 Feb 01; 29(1):62-75. PubMed ID: 18199690
    [Abstract] [Full Text] [Related]

  • 19. Membrane glycoprotein PC-1 and insulin resistance.
    Goldfine ID, Maddux BA, Youngren JF, Frittitta L, Trischitta V, Dohm GL.
    Mol Cell Biochem; 1998 May 01; 182(1-2):177-84. PubMed ID: 9609127
    [Abstract] [Full Text] [Related]

  • 20. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor.
    Elbaz N, Bedecs K, Masson M, Sutren M, Strosberg AD, Nahmias C.
    Mol Endocrinol; 2000 Jun 01; 14(6):795-804. PubMed ID: 10847582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.